Machine learning approaches to drug response prediction: challenges and recent progress.
George Adam1,2,3, Ladislav Rampášek2,3,4, Zhaleh Safikhani1,3,5
1Princess Margaret Cancer Centre, University Health Network, Toronto, ON Canada.
NPJ Precision Oncology
|June 23, 2020
Summary
Deep learning advances computational drug response prediction for personalized cancer therapy. New data and methods promise more accurate treatment selection to improve patient outcomes.
Area of Science:
- Oncology
- Computational Biology
- Bioinformatics
Background:
- Cancer remains a leading global cause of mortality.
- Personalized medicine through computational drug response prediction offers improved treatment success.
- Current computational models face challenges due to data limitations and algorithmic shortcomings.
Purpose of the Study:
- To review computational challenges and advances in predicting drug response for cancer.
- To compare machine learning techniques for practical clinical application by non-experts.
- To highlight the potential of deep learning in enhancing drug response prediction accuracy.
Main Methods:
- Review of existing literature on computational drug response prediction.
- Analysis of deep learning applications in oncology.
- Comparison of various machine learning techniques for their clinical utility.
Main Results:
- Deep learning shows significant promise for improving computational drug response prediction models.
- Machine learning techniques offer practical tools for clinicians and non-experts.
- Emerging data modalities like single-cell profiling are crucial for advancement.
Conclusions:
- Advances in deep learning and data integration are key to more accurate cancer drug response prediction.
- Accessible computational tools can aid clinicians in selecting optimal therapies.
- Future research should focus on integrating novel data and efficient drug combination discovery.
Related Concept Videos
Drug Discovery: Overview
10.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.7K
Factors Affecting Drug Response: Overview
2.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K
Structure-Activity Relationships and Drug Design
1.5K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
199
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
199
Analysis of Population Pharmacokinetic Data
597
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
597
Measurement of Bioavailability: Pharmacodynamic Methods
130
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
130


